Steve Schonfeld’s Organon & Co OGN Stock Holding History

Steve Schonfeld’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,525	Closed	-$628K	–	2888
2026 Q1	$315K	Buy	52,525 +22,539	+75%	+$170K	﹤0.01%	1562
2025 Q4	$215K	Sell	29,986 -415,071	-93%	-$3.28M	﹤0.01%	1695
2025 Q3	$4.75M	Sell	445,057 -39,801	-8%	-$391K	0.03%	605
2025 Q2	$4.69M	Buy	+484,858	New	+$5M	0.03%	585
2025 Q1	–	Sell	-63,669	Closed	-$950K	–	2423
2024 Q4	$950K	Buy	63,669 +42,103	+195%	+$686K	0.01%	1146
2024 Q3	$413K	Buy	+21,566	New	+$447K	﹤0.01%	1521
2023 Q4	–	Sell	-60,123	Closed	-$1.04M	–	2117
2023 Q3	$1.04M	Buy	+60,123	New	+$1.25M	0.01%	1008
2023 Q1	–	Sell	-21,535	Closed	-$601K	–	2489
2022 Q4	$601K	Buy	21,535 +12,635	+142%	+$323K	0.01%	1432
2022 Q3	$208K	Buy	+8,900	New	+$269K	﹤0.01%	2310
2022 Q1	–	Sell	-65,372	Closed	-$1.99M	–	2818
2021 Q4	$1.99M	Buy	+65,372	New	+$2.13M	0.02%	708

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Steve Schonfeld's OGN Position: Q2 2026 in Review

Steve Schonfeld sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 52,525 shares — an estimated $628K sold.

Steve Schonfeld first reported a position in OGN in Q4 2021 and held it in 10 quarters. The position peaked at $4.75M in Q3 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Steve Schonfeld reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Steve Schonfeld sold 52,525 Organon & Co shares in Q2 2026, an estimated $628K.
Steve Schonfeld first reported a position in Organon & Co in Q4 2021 and held it in 10 quarters.
Steve Schonfeld's Organon & Co position peaked at $4.75M in Q3 2025.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.